| 1. |
Harada K, Doki N, Aoki J, Mori J, Machida S, Masuko M, Uchida N, Najima Y, Fukuda T, Kanamori H, Ogawa H, Ota S, Ogawa K, Takahashi S, Kasai M, Maeda A, Nagafuji K, Kawakita T, Ichinohe T, Atsuta Y. Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15). Haematologica. 2018 Feb; 103(2):e69-e72. doi: 10.3324/haematol.2017.179804. |
| 2. |
Fujii S, Miura Y, Fujishiro A, Shindo T, Shimazu Y, Hirai H, Tahara H, Takaori-Kondo A, Ichinohe T*, Maekawa T*. (*co-senior author) Graft-versus-host disease amelioration by human bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles is associated with peripheral preservation of naive T Cell populations. Stem Cells. 2018 Mar; 36(3):434-445. doi: 10.1002/stem.2759. |
| 3. |
Yanada M, Mori J, Aoki, J, Harada K, Mizuno S, Uchida N, Kurosawa S, Toya T, Kanamori H, Ozawa Y, Ogawa H, Henzan H, Iwato K, Sakura T, Ota S, Fukuda T, Ichinohe T, Atsuta Y, Yano S. Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types allogeneic hematopoietic cell transplantation: an analysis of 7812 patients. Leuk Lymphoma. 2018 Mar;59(3):601-609. doi: 10.1080/10428194. |
| 4. |
Kikuchi J, Kuroda Y, Koyama D, Osada N, Izumi T, Yasui H, Kawase T, Ichinohe T, Furukawa Y. Myeloma cells are activated in bone marrow microenvironment by the CD180/MD-1 complex, which senses lipopolysaccharide. Cancer Res. 2018 Apr 1; 78(7): 1766-1778. doi: 10.1158/0008-5472.CAN-17-2446. |
| 5. |
Ichinohe T, Miyama T, Kawase T, Honjo Y, Kitaura K, Sato H, Shin-I T, Suzuki R. Next-generation immune repertoire sequencing as a clue to elucidate the landscape of immune modulation by host-gut microbiome interactions. Front Immunol. 2018 Apr 3; 9: 668. doi: 10.3389/fimmu.2018.00668. |
| 6. |
Yoshimitsu M, Tanosaki R, Kato K, Ishida T, Choi I, Takatsuka Y, Fukuda T, Eto T, Hidaka M, Uchida N, Miyamoto T, Nakashima Y, Moriuchi Y, Nagafuji K, Miyazaki Y, Ichinohe T, Takanashi M, Atsuta Y, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Risk assessment in adult T cell leukemia/lymphoma treated with allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2018 Apr;24(4):832-839. doi: 10.1016 /j.bbmt.2017.11.005. |
| 7. |
Yamamoto C, Ogawa H, Fukuda T, Igarashi A, Okumura H, Uchida N, Hidaka M, Nakamae H, Matsuoka KI, Eto T, Ichinohe T, Atsuta Y, Kanda Y. Impact of a low CD34+ cell dose on allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2018 Apr;24(4):708-716. doi: 10.1016 /j.bbmt.2017.10.043. |
| 8. |
Itonaga H, Aoki K, Aoki J, Ishikawa K, Ishiyama K, Uchida N, Sakura T, Ohashi K, Kurokawa M, Ozawa Y, Matsuoka KI, Nakamura Y, Kimura F, Iwato K, Nawa Y, Hirokawa M, Kato K, Ichinohe T, Atsuta Y, Miyazaki Y. Prognostic impact of donor source on allogeneic hematopoietic stem cell transplantation outcomes in adults with chronic myelomonocytic leukemia: a nationwide retrospective analysis in Japan. Biol Blood Marrow Transplant. 2018 Apr;24(4):840-848. doi: 10.1016 /j.bbmt.2017.11.016. |
| 9. |
Iida S, Ichinohe T, Shinagawa A, Suzuki K, Takezako N, Aoki M. Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma.. Int J Hematol. 2018 Apr;107(4):460-467. doi: 10.1007/s12185-017-2390-2. |
| 10. |
Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Inoue M, Fukuda T, Ichinohe T, Atsuta Y, Kanda Y. Homozygous HLA-C1 is associated with reduced risk of relapse after HLA-matched transplantation in patients with myeloid leukemia. Biol Blood Marrow Transplant. 2018 Apr;24(4):717-725. doi: 10.1016 /j.bbmt.2017.11.029. |
| 11. |
Ogawa H, Ikegame K, Daimon T, Uchida N, Fukuda T, Kakihira K, Eto T, Ozawa Y, Kanamori H, Hidaka M, Iwato Y, Ichinohe T, Takanashi M, Atsuta Y, Kanda Y. Impact of pretransplantation leukemic blast% in bone marrow and peripheral blood on transplantation outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation in non-CR. Bone Marrow Transplant. 2018 Apr;53(4):478-482. doi: 10.1038/s41409-017-0028-x. [EPub 2018 Jan 12]* |
| 12. |
Takimoto-Shimomura T, Nagoshi H, Maegawa S, Fujibayashi Y, Tsukamoto T, Tanba K, Matsumura-Kimoto Y, Mizuno Y, Chinen Y, Shimura Y, Kobayashi T, Horiike S, Tomohiko T, Taniwaki M, Kuroda J. Establishment and molecular characteristics of a novel mantle cell lymphoma-derived cell line and its a bendamustine-resistant subline with cross-resistance to various anticancer agents. Cancer Genomics Proteomics. 2018 May-Jun;15(3):213-223. |
| 13. |
Okada A, Harada Y, Inoue T, Okikawa Y, Ichinohe T, Kiuchi Y. A case of primary extranodal natural killer/T-cell lymphoma in the orbit and intraocular tissues with cerebrospinal fluid involvement. Am J Ophthalmol Case Rep. 2018 May 17; 11: 37-40. doi: 10.1016/j.ajoc.2018.05.002. |
| 14. |
Takei Y, Shen G, Morita-Kondo A, Hara T, Mihara K, Yanagihara K. MicroRNAs associated with epithelial-mesenchymal transition can be targeted to inhibit peritoneal dissemination of human scirrhous gastric cancers. Pathobiology. 2018;85(4):232-246. doi: 10.1159/000488801. [Epub 2018 May 30] |
| 15. |
Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M, Atsuta Y, Nakaseko C. Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan. Biol Blood Marrow Transplant. 2018 Jun: 24(6): 1180-1186. doi: 10.1016/j.bbmt.2018.01.026. |
| 16. |
Konuma T, Yanada M, Yamasaki S, Kuwatsuka Y, Fukuda T, Kobayashi T, Ozawa Y, Uchida N, Ota S, Hoshino T, Takahashi S, Kanda Y, Ueda Y, Takanashi M, Kanda J, Ichinohe T, Atsuta Y, Yano S. Allogeneic haematopoietic cell transplantation for adult acute myeloid leukaemia in second remission: a retrospective study of the Adult Acute Myeloid Leukaemia Working Group of the Japan Society for Haematopoietic Cell Transplantation (JSHCT). Br J Haematol. 2018 Jul; 182(2): 245-250. doi: 10.1111/bjh.15399. |
| 17. |
Toishigawa K, Nakagawa H, Furuta T, Fukushima N. Platelet satellitism. Intern Med. 2018 Jul 1:57(13):1949. doi:10.2169/internalmedicine.0119-17. |
| 18. |
Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, Ishida Y, Hashimoto H, Iwato K, Kanda Y, Kurokawa M, Nakazawa H, Ota S, Uchida N, Ichinohe T, Atsuta Y, Takaori-Kondo A. Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data. Biol Blood Marrow Transplant. 2018 Aug: 24(8): 1596-1601. doi: 10.1016/j.bbmt. 2018.03.009. |
| 19. |
Yamasaki S, Chihara D, Kim SW, Izutsu K, Iwato K, Fukuda T, Uchida N, Amano I, Nakazawa H, Kuroda J, Hashimoto H, Ichinohe T, Kanda Y, Atsuta Y, Suzumiya J, Suzuki R. Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma. Ann Hematol. 2018 Aug; 97(8): 1445-1452. doi: 10.1007/s00277-018-3318-5. Erratum in: Ann Hematol. 2018 Oct; 97(10): 2013-2014. |
| 20. |
Inamoto Y, Matsuda T, Tabuchi K, Kurosawa S, Nakasone H, Nishimori H, Yamasaki S, Doki N, Iwato K, Mori T, Takahashi S, Yabe H, Kohno A, Nakamae H, Sakura T, Hashimoto H, Sugita J, Ago H, Fukuda T, Ichinohe T, Atsuta Y, Yamashita T; Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group. Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation. Blood Adv. 2018 Aug 14; 2(15): 1901-1913. doi: 10.1182/bloodadvances.2018020966. |
| 21. |
Kako S, Fujiwara S, Sato M, Kimura SI, Nakasone H, Ohashi K, Kawakita T, Maeda T, Morishita T, Suzuki R, Fukuda T, Ichinohe T, Kurata M, Atsuta Y, Kanda Y. Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis. Biol Blood Marrow Transplant. 2018 Oct;24(10):2139-2144. doi: 10.1016/j.bbmt.2018.04.015. |
| 22. |
Yamasaki S, Chihara D, Kim SW, Izutsu K, Iwato K, Fukuda T, Uchida N, Amano I, Nakazawa H, Kuroda J, Hashimoto H, Ichinohe T, Kanda Y, Atsuta Y, Suzumiya J, Suzuki R. Correction to: Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma. Ann Hematol. 2018 Oct: 97(10): 2013-2014. doi: 10.1007/s00277-018-3450-2. |
| 23. |
Konuma T, Mizuno S, Kondo T, Yamaguchi H, Fukuda T, Uchida N, Najima Y, Kanamori H, Ota S, Nakamae H, Nakamae M, Mizuno I, Sugita J, Onishi Y, Yokota A, Takahashi S, Kanda Y, Ichinohe T, Atsuta Y, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT). Ann Hematol. 2018 Nov; 97(11): 2173-2183. doi: 10.1007/s00277-018-3419-1. |
| 24. |
Masuda J, Takayama E, Ichinohe T, Strober W, Mizuno-Kamiya M, Ikawa T, Kitani A, Kawaki H, Fuss I, Kawamoto H, Seno A, Vaidyanath A, Umemura N, Mizutani A, Kasai T, Honjo Y, Satoh A, Murakami H, Katsura Y, Kondoh N, Seno M. Suppression effect on IFN-γ of adipose tissue-derived mesenchymal stem cells isolated from β2-microglobulin-deficient mice. Exp Ther Med. 2018 Nov; 16(5): 4277-4282. doi: 10.3892/etm.2018.6689. |
| 25. |
Ohmachi K, Tobinai K, Kinoshita T, Ishikawa T, Hatake K, Ichikawa S, Ohmine K, Kamitsuji Y, Choi I, Chou T, Tsukasaki K, Kumagai K, Taniwaki M, Uchida T, Kikukawa Y, Kubo K, Mihara K, Tsukamoto N, Izutsu K, Yoshida I, Ishida F, Usui N, Iida S, Murayama T, Ueda E, Kuriki H, Ando K. Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial. Int J Hematol. 2018 Nov: 108(5): 499-509. doi: 10.1007/s12185-018-2497-0. |
| 26. |
Itonaga H, Ota S, Ikeda T, Taji H, Amano I, Hasegawa Y, Ichinohe T, Fukuda T, Atsuta T, Tanizawa A, Kondo T, Miyazaki Y. Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophilic leukemia: a retrospective nationwide study in Japan. Leuk Res. 2018 Dec;75:50-57. doi:10.1016 /j.leukres.2018.11.003. |
| 27. |
Fukushima N, Tomiyasu S, Uji Y, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Ichinohe T, Kimura S. Monitoring of citrulline and diamine oxidase levels as biomarkers for intestinal mucositis during early phase of hematopoietic cell transplantation. Blood Cell Therapy. 2018 1(1):1-8. doi:org/10.31547/bct-2017-002. |
